# Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine

> **NCT01022021** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Bendamustine

## Key facts

- **NCT ID:** NCT01022021
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2014-04
- **Final completion:** 2015-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01022021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01022021, "Peripheral Blood Stem Cell (PBSC) Mobilization in Patients With Relapsed Lymphoma Treated With Bendamustine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01022021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*